Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years.
about
Surgical resection versus liver transplant for patients with hepatocellular carcinomaRefining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterionDiabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysisSystematic review of actual 10-year survival following resection for hepatocellular carcinomaSurgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative techniquePreoperative galactose elimination capacity predicts complications and survival after hepatic resectionTreatment of hepatocellular carcinoma by percutaneous laser hyperthermia.Laparoscopic liver resections: a feasibility study in 30 patients.Potential applications of N-terminal recombinant fragments of bactericidal/permeability-increasing protein in liver surgery.Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis.Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: is it necessary?Viruses and hepatocellular carcinoma.An analysis of 412 cases of hepatocellular carcinoma at a Western center.Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomyRole of radiotherapy in the management of hepatocellular carcinoma: A systematic review.Herbal medicine and hepatocellular carcinoma: applications and challengesRefusal of cancer-directed surgery strongly impairs survival of patients with localized hepatocellular carcinoma.Surgical management of hepatic malignancy.Systems analysis of non-parenchymal cell modulation of liver repair across multiple regeneration modes.RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma.Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis.The combination of three molecular markers can be a valuable predictive tool for the prognosis of hepatocellular carcinoma patients.Hepatocellular carcinoma: clinical study of long-term survival and choice of treatment modalitiesLaparoscopic liver resection for malignant liver tumors, why not more?Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention.Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.Dual oxidase 1: A predictive tool for the prognosis of hepatocellular carcinoma patients.Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma.Perioperative ischaemia-induced liver injury and protection strategies: An expanding horizon for anaesthesiologists.Optimized management of advanced hepatocellular carcinoma: four long-lasting responses to sorafenib.Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase.Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases.Preoperative assessment of mortality risk in hepatic resection by clinical variables: a multivariate analysis.Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters.Prognostic factors and 10-year survival in patients with hepatocellular carcinoma after curative hepatectomy.Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients.Analysis of risk factors for hyperbilirubinemia occurring after hepatectomy.Sectionectomy is suitable for patients with T2 hepatocellular carcinoma according to the modified international union against cancer TNM Classification.Clinical results of proton beam therapy for hepatocellular carcinoma over 5 cm.
P2860
Q24201773-E1B45248-A3BA-4F47-9200-CCFBACDDAA8FQ24633990-8FC45CE8-747F-491A-B612-B4158DF7FB5EQ26864963-49DE859A-C728-406B-9210-35E3FD7B599EQ26998612-53B049E8-A946-45AC-B25A-BDC63302EBF5Q27690723-364B0BE3-A896-4FF1-9488-DA63B0A0A0E3Q28344083-926A23B1-0F19-4364-A72E-A0212D0C757EQ30989183-24D392C1-1228-4935-BB76-CC88EEA9F769Q33181471-09D13870-E5F8-4835-BDD2-6A0C0851A9D2Q33539885-BF936380-1485-4A94-8653-5F5404329F0EQ33751641-5272A04E-B352-40A6-84D9-98218E385605Q33830734-61F52623-693B-41D4-89F7-BAE152820520Q34379306-AE792D54-B002-4FC2-9C80-7A10C9ADEC71Q34503813-B3F96490-594F-49A3-8702-1C9D7915CFA2Q34512035-AE646204-A028-4546-B30D-883BD9EC6081Q34768282-4515445C-AAD9-42A8-B01B-B02BA6D36230Q34966816-C73E5197-198A-4AFA-AB23-D5F5A9CC15D8Q35117008-B48B4B84-05C7-4743-BAD9-1A98702CE2B8Q35692190-47FF3F0A-B369-4D1A-A7DE-C6DF644BFC0EQ35806757-7B1766C0-08D9-449D-87F4-F0D22EB95617Q35817872-EF4300C5-FBFB-4294-BA7F-2C541B42D2F3Q35832116-259A5953-8324-401F-97F8-B4243C10BBDBQ36179777-CD8C7FAC-AD13-41A7-A066-8D5BC6B6E49EQ36799987-C556291D-EBC4-4FDE-890D-463DC78BD250Q36950854-9BD8633B-50A1-40D8-A0C4-4191032888F2Q38026053-54F614E7-AF5D-408B-B7AC-5F1C758E1EE8Q38129312-20691983-C118-4CF1-9E1F-810A5E5ECDAAQ39883398-9F3D233A-B20B-487F-92C4-8968B4C5C984Q40701503-7F8749CD-456F-4C30-AD92-A2AB45D87B49Q40866847-E782183A-A3A9-4875-A227-47E2B29D0A12Q42562141-AE96E591-1A3C-4E34-9D32-50B4A8058DB6Q42740868-6B2D547D-3524-4A72-A56F-BE1BFC80A3F6Q43038834-5FBDE37E-92C4-41A6-BE5D-8CC0C53FE1B4Q44732885-9315C8D8-69D2-4A8B-A36C-2850BBD8572EQ44745387-01AB6531-CB65-45D1-961E-6474CB9CEFE0Q45842965-8F708E60-94F2-4EF8-8039-05EC1BEE7050Q46555327-073AEA34-507B-45B6-95D4-D405AD033037Q47616067-64D5180B-4C99-411A-B38C-887AFA42BD6AQ51580320-AB352339-A0BB-4735-BC2B-65205707C3D4Q53229727-F5D3412A-461E-49E9-91DB-BD8FE08C9E35Q53505408-98AA7E72-43E8-460F-83A5-94EC6F01873A
P2860
Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Liver resection for hepatocell ...... tive patients during 11 years.
@en
type
label
Liver resection for hepatocell ...... tive patients during 11 years.
@en
prefLabel
Liver resection for hepatocell ...... tive patients during 11 years.
@en
P2093
P1433
P1476
Liver resection for hepatocell ...... tive patients during 11 years.
@en
P2093
Nakamura T
Takemoto Y
P304
P356
10.1097/00000658-199304000-00009
P407
P577
1993-04-01T00:00:00Z